The termination does not impact Medtronic’s fiscal year 2024 adjusted earnings per share guidance range that the company provided on November 21, 2023. Medtronic continues to advance its automated insulin dosing product pipeline, including a differentiated patch pump.
Related Posts
Shhh….Tomorrow’s Market Secrets – Delivered Today
Market Briefing As we begin a critical stretch in the second full week of May, traders are navigating a landscape…
US Stock Futures Waver After 7-Week Winning Streak: Analyst Sees More Gains Piling Up On Dow’s Record Highs
U.S. stock futures indicate a cautious opening on Monday after the market’s seven consecutive weekly winning streak. As the time…
C3.ai Q2 Earnings Highlights: Revenue Miss, EPS Beat, ‘Unprecedented Interest And Traction’ In Generative AI Offerings
C3.Ai Inc (NYSE:AI) reported fiscal second-quarter financial results Wednesday after the bell. Here’s a look at the key metrics from the…